Reply to the letter to the editor'What is the clinical impact ofthe LUX-Lung 5 trial?' by Addeo
Journal
Annals of Oncology
Journal Volume
27
Journal Issue
6
Pages
1172-1173
Date Issued
2016
Author(s)
SDGs
Other Subjects
afatinib; epidermal growth factor receptor; erlotinib; gefitinib; osimertinib; paclitaxel; Article; cancer research; EGFR gene; gene mutation; human; metastasis; monotherapy; non small cell lung cancer; phase 3 clinical trial (topic); priority journal; progression free survival; randomized controlled trial (topic); relapse; lung; lung tumor; non small cell lung cancer; Carcinoma, Non-Small-Cell Lung; Humans; Lung; Lung Neoplasms
Publisher
Oxford University Press
Type
journal article